Germany: BfR Highlights Supplement Risks, Emphasises Consumer Information Needs
Germany's Federal Institute for Risk Assessment (BfR) has launched a dedicated online portal for micronutrients and supplements, underscoring persistent concerns regarding consumer understanding and product safety within the German market.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
The German Federal Institute for Risk Assessment (BfR) has expanded its public information resources, prominently featuring a new portal, 'Mikronährstoffe und Co.' (microco-wissen.de), dedicated to vitamins, minerals, and other substances found in food supplements (Nahrungsergänzungsmittel - NEM). This initiative centralises BfR's scientific evaluations and consumer-focused information on supplement ingredients, their safety, and efficacy. The BfR, an independent scientific institution advising the German federal government, is intensifying its focus on communicating potential health risks associated with various consumer products, including food and feed, chemicals, and cosmetics. Its mandate extends to assessing ingredient release from packaging and monitoring emerging contaminants.
Recent BfR communications include detailed responses on Bisphenol A (BPA) in everyday products, demonstrating the institute's commitment to evaluating cumulative consumer exposure to chemicals. Although not directly related to supplements, this highlights the BfR's rigorous approach to chemical safety assessment that can influence ingredient approval and packaging standards for the supplement sector. The BfR also acts as Germany's national contact point for the European Food Safety Authority (EFSA), ensuring alignment with broader EU food safety directives and scientific information exchange.
This increased public communication and resource centralisation on supplements reflect the BfR's ongoing efforts to manage consumer expectations and mitigate perceived risks within the market. Brand owners and manufacturers operating in Germany must recognise this as a signal for enhanced regulatory oversight and consumer scrutiny. The BfR's focus on transparent risk communication aims to empower consumers, which in turn demands greater transparency and scientific rigour from industry participants.
What this means for Germany
German supplement manufacturers and brand owners must align product development and marketing with BfR's explicit guidance, particularly regarding dosage and approved claims. Reformulation windows for existing products may shorten as new scientific insights from BfR or EFSA emerge, potentially increasing manufacturing costs by 3-7% for ingredient sourcing or process adjustments. Procurement teams should prioritise suppliers capable of providing comprehensive toxicological data and clear certificates of analysis to navigate stricter scrutiny. Brand positioning should emphasise transparency and scientific backing, avoiding unsubstantiated health claims that could attract regulatory attention or consumer distrust. Regulatory affairs teams need to proactively monitor BfR publications and EFSA opinions to pre-empt compliance deadlines.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.